Peptide Science research editorial team.
Vesilute 20mg (Bioregulator) Overview
Vesilute 20mg from Peptide Science is the synthetic Khavinson short-peptide bioregulator derived from vascular-system tissue fractions, supplied as a lyophilised vial for in-vitro and preclinical vascular-endothelial-cell research.
Khavinson Short-Peptide Class Background
Vesilute 20mg (Bioregulator) belongs to the Khavinson short-peptide family, a class of synthetic two-to-four-residue peptides originally derived from bioregulator-fraction extracts of mammalian tissues by V. Kh. Khavinson and colleagues from the 1980s onward. The class is characterised by short sequence length (typically 2 to 4 amino acids), organ-specific source-tissue derivation, and synthetic reconstitution of the original tissue-fraction activity. The full class includes Epithalon (pineal), Cortexin (cerebral cortex), Pinealon (pineal), Vesugen (vascular), and the dozen organ-specific bioregulators in this catalogue.
Vascular/Endothelial Bioregulator Research Context
Vesilute is studied in preclinical research for vascular-cell signalling pathways. The compound is the vascular-targeted member of the Khavinson family alongside Vesugen, supporting comparative cardiovascular-system research across the multiple vascular short peptides in the class. Browse the broader bioregulator peptide range for related Khavinson short peptides.
Vial Specifications
| Property | Value |
|---|---|
| Compound | Vesilute 20mg (Bioregulator) |
| Class | Khavinson short-peptide bioregulator |
| Source-tissue derivation | Vascular-system tissue fraction |
| Supplied form | Lyophilised powder, sealed vial |
| Strength | 20 mg per vial |
| Purity | greater than 99 percent (HPLC verified) |
| Storage | 2 to 8 degrees Celsius lyophilised; minus 20 degrees Celsius long-term |
For paired research with the related vascular Khavinson bioregulator, see Vesugen 20mg, and with the cardiac-muscle-derived bioregulator, see Cardiogen 20mg.
Reconstitution and Handling
The lyophilised short peptide reconstitutes with bacteriostatic water at the working concentration set by the principal investigator. Aliquoting reconstituted stock for single-use frozen storage is the standard handling practice cited in Khavinson-tradition research protocols.
Quality and Shipping
Each batch passes HPLC at greater than 99 percent purity, with mass-spectrometry identity confirmation. A Certificate of Analysis accompanies every order. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging via overnight or two-day courier.
For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws. Lyophilised vials store at 2 to 8 degrees Celsius; protect from light.





Reviews
There are no reviews yet.